KIZELMY
Live / Registered — Registered (as of 19 May 2026)
What this means for you
Registered since 19 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2032: the §71 affidavit of use).
Record
- Serial number
- 79437892
- Registration number
- 8258482
- Mark type
- Word mark
- Filed
- 16 Oct 2025
- Published for opposition
- 31 Mar 2026
- Registered
- 19 May 2026
- Next maintenance filing
- §71 affidavit of use, due by 19 May 2032 (grace period to 19 Nov 2032)
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases.
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 18 Jun 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTICE OF PUBLICATION
- 05 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2026 — ASSIGNED TO EXAMINER
- 02 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 02 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB